Armata Pharmaceuticals, Inc. (ARMP)

[lesgetrich]

There are two observations that I would caution you about regarding your analysis.

First, ARMP has an extraordinarily low OS. As of June 30, there were only 5,069,633 shares outstanding. Anyone buying or selling a few hundred shares on any given day can substantially change the pps which should make this stock very volatile. It seems currently like those who've decided, like you, that it will be awhile before Armata becomes profitable, have already sold their shares. I suspect that the remaining shareholders are more willing to wait long term which will put upward pressure on the pps until or unless we hit a recession or major market sell off which leads to margin selling.

Second, we are looking at a life saving technology not a simple arthritis cream. Phage therapy has already proven itself in small unofficial trials. There will be extreme pressure on the FDA to approve early distribution if the preliminary results show as much effectiveness as the early trials.